Compare MOMO & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MOMO | AORT |
|---|---|---|
| Founded | 2011 | 1984 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 2.1B |
| IPO Year | 2014 | 1993 |
| Metric | MOMO | AORT |
|---|---|---|
| Price | $6.74 | $44.94 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | $13.00 | ★ $49.36 |
| AVG Volume (30 Days) | ★ 873.8K | 346.5K |
| Earning Date | 12-10-2025 | 11-06-2025 |
| Dividend Yield | ★ 4.44% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.60 | N/A |
| Revenue | ★ $1,464,746,462.00 | $422,646,000.00 |
| Revenue This Year | $0.30 | $15.97 |
| Revenue Next Year | $3.19 | $10.96 |
| P/E Ratio | $11.17 | ★ N/A |
| Revenue Growth | N/A | ★ 9.81 |
| 52 Week Low | $5.12 | $21.97 |
| 52 Week High | $9.22 | $48.04 |
| Indicator | MOMO | AORT |
|---|---|---|
| Relative Strength Index (RSI) | 42.90 | 51.19 |
| Support Level | $6.46 | $42.68 |
| Resistance Level | $7.10 | $46.02 |
| Average True Range (ATR) | 0.18 | 1.35 |
| MACD | -0.03 | -0.18 |
| Stochastic Oscillator | 41.62 | 53.39 |
Hello Group Inc provides mobile-based social networking services. It enables users to establish and expand social relationships based on location and interests. Its platform includes the Momo mobile application and a variety of related features, functionalities, tools, and services that it provides to users, customers, and platform partners. The company derives its revenue from live video services, value-added services, mobile marketing services, mobile games, and other services. It operates in three segments: Momo's service lines, Tantan's service lines, and QOOL's service lines, out of which Momo's service lines segment derives the majority of revenue.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.